| Financial Year |
March 31 2023 |
| Monetary Funds |
117,286,775.92 |
| Held-for-trading Financial Assets |
368,037,540.35 |
| Notes Receivable |
-- |
| Accounts Receivable |
39,880,846.77 |
| Advances to Suppliers |
6,122,202.93 |
| Other Receivables |
4,441,970.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
140,989,089.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
94,609,629.78 |
| Total Current Assets |
771,500,535.58 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
64,595,389.26 |
| Fixed Assetes |
182,350,103.31 |
| Under-construction Projects |
34,501,288.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,156,089.98 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
285,993.29 |
| Deferred Income Tax Assets |
3,035,573.48 |
| Other Non-Current Assets |
10,731,975.43 |
| Sub-Total of Non-Current Assets |
413,803,762.81 |
| Total Assets |
1,185,304,298.39 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
40,690,282.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,565,905.30 |
| Taxes Payable |
9,873,730.19 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,082,691.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,583,747.67 |
| Other Current Liabilities |
1,868,696.64 |
| Sub-Total of Current Liabilities |
109,971,609.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,837,721.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
29,750,425.80 |
| Total Liabilities |
139,722,035.41 |
| Paid-In Capital(Or Share Stock) |
804,040,313.00 |
| Capital Surplus |
1,345,550,547.35 |
| Surplus Reserve |
22,193,765.40 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,215,473,863.18 |
| Minority Stockholder's Interest |
46,955,669.49 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
998,626,593.49 |
| Owner's Equity（Stockholder's Equity） |
1,045,582,262.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,185,304,298.39 |
